Growth Metrics

Pulmonx (LUNG) Gross Profit (2019 - 2025)

Pulmonx has reported Gross Profit over the past 7 years, most recently at $16.1 million for Q3 2025.

  • Quarterly Gross Profit rose 6.83% to $16.1 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $67.2 million through Sep 2025, up 14.24% year-over-year, with the annual reading at $62.0 million for FY2024, 22.16% up from the prior year.
  • Gross Profit was $16.1 million for Q3 2025 at Pulmonx, down from $17.2 million in the prior quarter.
  • Over five years, Gross Profit peaked at $17.6 million in Q4 2024 and troughed at $6.6 million in Q1 2021.
  • The 5-year median for Gross Profit is $12.7 million (2023), against an average of $12.5 million.
  • Year-over-year, Gross Profit soared 792.19% in 2021 and then increased 4.24% in 2022.
  • A 5-year view of Gross Profit shows it stood at $10.3 million in 2021, then increased by 9.1% to $11.2 million in 2022, then grew by 28.76% to $14.4 million in 2023, then rose by 22.15% to $17.6 million in 2024, then dropped by 8.74% to $16.1 million in 2025.
  • Per Business Quant, the three most recent readings for LUNG's Gross Profit are $16.1 million (Q3 2025), $17.2 million (Q2 2025), and $16.3 million (Q1 2025).